Standing Order
Novartis AG

Dashboard

Novartis AG

NVSNYSE

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$284B
Price$150.4752w $113.50 – $168.62
Conviction5/ 5
Revenue (TTM)$56.3B
Revenue growth YoY-0.1%
P/E (trailing)28.3
Gross margin74.6%
Operating margin25.5%
Net margin17.8%
52w price change+27.5%
Next earnings—

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Nov 19
    OtherSEC

    Novartis AG filed Form 6-K with the SEC on 2026-11-19.

  • Nov 12
    OtherSEC

    Novartis AG filed Form 6-K with the SEC on 2026-11-12.

  • Nov 10
    Securities offeringSEC

    Novartis AG filed 424B5 prospectus supplement for securities offering.

  • Nov 9
    Securities offeringSEC

    Novartis filed SEC Form 424B5 prospectus supplement.

  • Oct 27
    OtherSEC

    Novartis AG filed Form 6-K with the SEC on 2026-10-27.

  • Sep 8
    OtherSEC

    Novartis AG filed Form 6-K with the SEC on 2026-09-08.

  • Sep 4
    OtherSEC

    Novartis AG filed Form 6-K foreign issuer report.

  • Sep 1
    OtherSEC

    Novartis AG filed Form 6-K with the SEC on 2026-09-01.

  • Jul 21
    Financial resultsSEC

    Novartis AG filed Form 6-K containing quarterly financial information for period ended June 30, 2026.

  • Jun 11
    OtherSEC

    Novartis AG filed Form 6-K with the SEC.

Not financial advice — research and opinion only. Disclosures